ZECCA, LUIGI
ZECCA, LUIGI
Istituto di Tecnologie Biomediche - ITB
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease
2023 Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
2023 Zucca F.A.; Capucciati A.; Bellei C.; Sarna M.; Sarna T.; Monzani E.; Casella L.; Zecca L.
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease
2023 Nagatsu T.; Nakashima A.; Watanabe H.; Ito S.; Wakamatsu K.; Zucca F.A.; Zecca L.; Youdim M.; Wulf M.; Riederer P.; Dijkstra J.M.
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
2022 Wise R.M.; Wagener A.; Fietzek U.M.; Klopstock T.; Mosharov E.V.; Zucca F.A.; Sulzer D.; Zecca L.; Burbulla L.F.
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus
2022 Capucciati A.; Monzani E.; Sturini M.; Nicolis S.; Zucca F.A.; Bubacco L.; Bortolus M.; Zecca L.; Casella L.
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells
2021 Sulkowski M.; Kot M.; Badyra B.; Paluszkiewicz A.; Plonka P.M.; Sarna M.; MichalczykWetula D.; Zucca F.A.; Zecca L.; Majka M.
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
2021 Capucciati, A; Zucca, Fa; Monzani, E; Zecca, L; Casella, L; Hofer, T
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease.
2021 Zecca L; Pifl C; Fahn S; Sulzer D; Fariello RG
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects
2021 Cupaioli, Fa; Zucca, Fa; Caporale, C; Lesch, Kp; Passamonti, L; Zecca, L
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
2020 Sulzer D; Antonini A; Leta V; Nordvig A; Smeyne RJ; Goldman JE; AlDalahmah O; Zecca L; Sette A; Bubacco L; Meucci O; Moro E; Harms AS; Xu Y; Fahn S; Ray Chaudhuri K
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI
2020 Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi Dargham A; Martinez D; Horga G
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
2019 Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology
2019 Möller, He; Bossoni, L; Connor, Jr; Crichton, Rr; Does, Md; Ward, Rj; Zecca, L; Zucca, Fa; Ronen, I
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases.
2019 Betts, Mj; Kirilina, E; Otaduy, Mcg; Ivanov, D; Acostacabronero, J; Callaghan, Mf; Lambert, C; Cardenasblanco, A; Pine, K; Passamonti, L; Loane, C; Keuken, Mc; Trujillo, P; Lüsebrink, F; Mattern, H; Liu, Ky; Priovoulos, N; Fliessbach, K; Dahl, Mj; Maaß, A; Madelung, Cf; Meder, D; Ehrenberg, Aj; Speck, O; Weiskopf, N; Dolan, R; Inglis, B; Tosun, D; Morawski, M; Zucca, Fa; Siebner, Hr; Mather, M; Uludag, K; Heinsen, H; Poser, Ba; Howard, R; Zecca, L; Rowe, Jb; Grinberg, Lt; Jacobs, Hil; Düzel, E; Hämmerer, D
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
2019 Cassidy C.M.; Zucca F.A.; Girgis R.R.; Baker S.C.; Weinstein J.J.; Sharp M.E.; Bellei C.; Valmadre A.; Vanegas N.; Kegeles L.S.; Brucato G.; Kang U.J.; Sulzer D.; Zecca L.; AbiDargham A.; Horga G.
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease
2019 Seguraaguilar, J; Sulzer, D; Zucca, Fa; Zecca, L
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
2019 Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G.
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease
2018 Sulzer D.; Cassidy C.; Horga G.; Kang U.J.; Fahn S.; Casella L.; Pezzoli G.; Langley J.; Hu X.P.; Zucca F.A.; Isaias I.U.; Zecca L.
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease
2018 Zucca, Fa; Vanna, R; Cupaioli, Fa; Bellei, C; De Palma, A; Di Silvestre, D; Mauri, P; Grassi, S; Prinetti, A; Casella, L; Sulzer, D; Zecca, L
Contrast mechanisms associated with neuromelanin-MRI
2017 Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease | 1-gen-2023 | Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X | |
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role | 1-gen-2023 | Zucca F.A.; Capucciati A.; Bellei C.; Sarna M.; Sarna T.; Monzani E.; Casella L.; Zecca L. | |
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease | 1-gen-2023 | Nagatsu T.; Nakashima A.; Watanabe H.; Ito S.; Wakamatsu K.; Zucca F.A.; Zecca L.; Youdim M.; Wulf M.; Riederer P.; Dijkstra J.M. | |
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders | 1-gen-2022 | Wise R.M.; Wagener A.; Fietzek U.M.; Klopstock T.; Mosharov E.V.; Zucca F.A.; Sulzer D.; Zecca L.; Burbulla L.F. | |
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus | 1-gen-2022 | Capucciati A.; Monzani E.; Sturini M.; Nicolis S.; Zucca F.A.; Bubacco L.; Bortolus M.; Zecca L.; Casella L. | |
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells | 1-gen-2021 | Sulkowski M.; Kot M.; Badyra B.; Paluszkiewicz A.; Plonka P.M.; Sarna M.; MichalczykWetula D.; Zucca F.A.; Zecca L.; Majka M. | |
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models | 1-gen-2021 | Capucciati, A; Zucca, Fa; Monzani, E; Zecca, L; Casella, L; Hofer, T | |
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease. | 1-gen-2021 | Zecca L; Pifl C; Fahn S; Sulzer D; Fariello RG | |
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects | 1-gen-2021 | Cupaioli, Fa; Zucca, Fa; Caporale, C; Lesch, Kp; Passamonti, L; Zecca, L | |
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside | 1-gen-2020 | Sulzer D; Antonini A; Leta V; Nordvig A; Smeyne RJ; Goldman JE; AlDalahmah O; Zecca L; Sette A; Bubacco L; Meucci O; Moro E; Harms AS; Xu Y; Fahn S; Ray Chaudhuri K | |
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI | 1-gen-2020 | Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi Dargham A; Martinez D; Horga G | |
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases | 1-gen-2019 | Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L | |
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology | 1-gen-2019 | Möller, He; Bossoni, L; Connor, Jr; Crichton, Rr; Does, Md; Ward, Rj; Zecca, L; Zucca, Fa; Ronen, I | |
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. | 1-gen-2019 | Betts, Mj; Kirilina, E; Otaduy, Mcg; Ivanov, D; Acostacabronero, J; Callaghan, Mf; Lambert, C; Cardenasblanco, A; Pine, K; Passamonti, L; Loane, C; Keuken, Mc; Trujillo, P; Lüsebrink, F; Mattern, H; Liu, Ky; Priovoulos, N; Fliessbach, K; Dahl, Mj; Maaß, A; Madelung, Cf; Meder, D; Ehrenberg, Aj; Speck, O; Weiskopf, N; Dolan, R; Inglis, B; Tosun, D; Morawski, M; Zucca, Fa; Siebner, Hr; Mather, M; Uludag, K; Heinsen, H; Poser, Ba; Howard, R; Zecca, L; Rowe, Jb; Grinberg, Lt; Jacobs, Hil; Düzel, E; Hämmerer, D | |
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain | 1-gen-2019 | Cassidy C.M.; Zucca F.A.; Girgis R.R.; Baker S.C.; Weinstein J.J.; Sharp M.E.; Bellei C.; Valmadre A.; Vanegas N.; Kegeles L.S.; Brucato G.; Kang U.J.; Sulzer D.; Zecca L.; AbiDargham A.; Horga G. | |
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease | 1-gen-2019 | Seguraaguilar, J; Sulzer, D; Zucca, Fa; Zecca, L | |
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism | 1-gen-2019 | Barichella M; Severgnini M; Cilia R; Cassani E; Bolliri C; Caronni S; Ferri V; Cancello R; Ceccarani C; Faierman S; Pinelli G; De Bellis G; Zecca L; Cereda E; Consolandi C; Pezzoli G. | |
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease | 1-gen-2018 | Sulzer D.; Cassidy C.; Horga G.; Kang U.J.; Fahn S.; Casella L.; Pezzoli G.; Langley J.; Hu X.P.; Zucca F.A.; Isaias I.U.; Zecca L. | |
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease | 1-gen-2018 | Zucca, Fa; Vanna, R; Cupaioli, Fa; Bellei, C; De Palma, A; Di Silvestre, D; Mauri, P; Grassi, S; Prinetti, A; Casella, L; Sulzer, D; Zecca, L | |
Contrast mechanisms associated with neuromelanin-MRI | 1-gen-2017 | Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A. |